388610 — Gfc Life Science Co Balance Sheet
0.000.00%
Consumer DefensivesHighly SpeculativeSmall Cap
- KR₩117bn
- KR₩124bn
- KR₩17bn
Annual balance sheet for Gfc Life Science Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | Annual Audited Accounts | ARS | ARS | ARS |
Standards: | KAS | KAS | KAS | KAS |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 1,210 | 625 | 1,483 | 1,538 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 1,717 | 2,214 | 2,086 | 1,764 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 3,699 | 3,402 | 4,396 | 3,947 |
Net Property, Plant And Equipment | 12,797 | 13,623 | 12,334 | 14,501 |
Net Intangible Assets | ||||
Long Term Investments | ||||
Other Long Term Assets | ||||
Total Assets | 18,023 | 19,857 | 18,838 | 20,055 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 6,998 | 20,516 | 18,294 | 6,867 |
Long Term Debt | ||||
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 9,788 | 16,586 | 20,001 | 9,155 |
Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Treasury Stock | ||||
ESOP Debt Guarantee | ||||
Other Equity | ||||
Total Equity | 8,235 | 3,271 | -1,164 | 10,900 |
Total Liabilities & Shareholders' Equity | 18,023 | 19,857 | 18,838 | 20,055 |
Total Common Shares Outstanding | ||||
Total Preferred Shares Outstanding |